THE SHARE: Change: -0.01 SEK (-4.65%) / Price: 0.18 SEK / May 19, 2025, 1:13 pm (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

Q1

  • 7 May, 2025
    Spago Nanomedical delårsrapport januari-mars 2025
  • 7 May, 2025
    Spago Nanomedical interim report January-March, 2025
  • 2 May, 2024
    Spago Nanomedical delårsrapport januari-mars 2024
  • 2 May, 2024
    Spago Nanomedical interim report January-March 2024
  • 9 May, 2023
    Spago Nanomedical delårsrapport januari-mars 2023
  • 9 May, 2023
    Spago Nanomedical interim report January-March 2023
  • 27 Apr, 2022
    Spago Nanomedical delårsrapport januari-mars 2022
  • 27 Apr, 2022
    Spago Nanomedical interim report January-March 2022
  • 28 Apr, 2021
    Spago Nanomedical interim report January-March 2021
  • 28 Apr, 2021
    Spago Nanomedical delårsrapport januari-mars 2021
  • 1
  • 2
  • Next
Back

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2025 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications